Introduction {#s1}
============

Over the past six decades, extracranial carotid artery stenosis has been considered as a risk factor for stroke ([@B1]). Severe stenosis of the internal carotid artery (ICA) may increase the risk of stroke. Compared with patients who did not receive endarterectomy, in patients with ICA stenosis severity \>70% with symptoms of stroke or transient ischemic attack (TIA), those who received endarterectomy are at a decreased risk of recurrent stroke ([@B2], [@B3]). In a 10-year follow-up study, Liapis et al. found that 19% of patients exhibited drastic stenosis progression in the ICA ([@B4]). Carotid stenosis is related to the formation of plaque in the carotid artery, and further development of such plaque may increase the rate of stenosis. Other factors that may increase the rate of stenosis progression in the ICA include diastolic blood pressure, diabetes mellitus, male sex, and turbulent blood flow ([@B2], [@B5]). Other factors that may increase the progression of carotid atherosclerosis include high plasma homocysteine levels, high plasma carotenoid levels ([@B6]), low plasma folate and vitamin B~6~ concentrations, and psychological stress. The progression of carotid artery stenosis may also be affected by the patients\' lifestyles and daily activity levels ([@B7], [@B8]). Severe stenosis in the extracranial carotid artery is common among Taiwanese patients with ischemic stroke ([@B9]). Carotid stenosis can be estimated through noninvasive ultrasonography, which is now widely used to investigate atherosclerosis in patients with ischemic stroke. An increasing number of patients have been referred for carotid ultrasonography due to the relative ease and noninvasiveness of this examination method. Guidelines for the general management of patients with acute ischemic stroke recommend ultrasound as the first-line method for examination of the carotid artery after TIA or stroke ([@B10]). However, no guideline exists for the duration of follow-up of patients with ischemic stroke through carotid artery ultrasound. This study aims to investigate the progression rate of ICA stenosis and the factors that affect stenosis progression in patients with ischemic stroke. The adequate duration of follow-up for patients with ischemic stroke through carotid artery ultrasound was also investigated.

Methods {#s2}
=======

Data source
-----------

In this retrospective study, clinical information was collected from a stroke registration database in a single teaching hospital for patients admitted between January 1, 2013 and December 31, 2013. The hospital is an acute care, 1,000-bed teaching hospital in central Taiwan. All patients underwent baseline carotid artery ultrasonography during hospitalization for acute stroke. All patients who were followed up through carotid artery ultrasonography for 2.5--3.5 years (mean 36.5 ± 3.5 months) after stroke onset were included in this study. The following exclusion criteria were applied: 1. ICA stenosis ≥70%, 2. Receipt of carotid artery stent implantation, and 3. Tortuosity of ICA. A flow chart of patient enrollment and exclusion is shown in Figure [1](#F1){ref-type="fig"}. There was no significant difference in risk factors for stroke between the study participants and those were excluded from the study \[hypertension (*p* = 0.2), diabetes mellitus (*p* = 1.0), hypercholesterolemia (*p* = 0.27) and hyper-LDL-cholesterolemia (*p* = 0.6)\].

![Flow chart of patient enrollment.](fneur-09-01043-g0001){#F1}

Hypertension was defined as systolic blood pressure ≥140 mmHg or diastolic blood pressure \>90 mmHg or on the basis of a self-reported history of hypertension or use of antihypertensive agents. Diabetes mellitus was defined as pathologically elevated fasting blood sugar or on the basis of a self-reported patient history of diabetes mellitus or regular use of anti-diabetic medications. Hypercholesterolemia was defined as a total cholesterol level \>200 mg/dl, hypertriglyceridemia was defined as a serum triglyceride level \>160 mg/dl and hyper-LDL-c was defined as low-density-lipoprotein cholesterol (LDL) \>130mg/dl (measured during acute stroke stage). Statin use was defined as patient statin possession ratio \>80% (number of days of statin supply divided by the number of days in the follow up period).

Carotid artery measures
-----------------------

Duplex sonographic examinations were performed in the neurophysiological laboratory of the hospital. Examinations were performed with either an Acuson sequoia or a PHILPS iE33 color duplex scanner. All examinations were performed by a well-trained technologist. The technician was blind to the previous measurement and patient\'s clinical details. The bilateral ICA, external carotid artery, and vertebral artery were examined through gray-scale imaging, color duplex imaging, and spectral analysis. Peak systolic blood flow velocity and end-diastolic flow velocity were measured through spectral analysis. During examination, the patients were in the supine position, with their head rotated 45° to the opposite side of the carotid artery being imaged. Initially, a transverse sweep was performed from the lower neck upward to the carotid artery bifurcation and then into the ICA. The flow velocity and stenosis rate were measured at the site of the common carotid artery, bulb, and proximal ICA. The degree of carotid artery stenosis was estimated in accordance with the European Carotid Surgery Trial by using the following equation: 1 -- (narrowest ICA diameter/total lumen diameter at narrowest site) ([@B2], [@B11], [@B12]). The severity of stenosis was categorized into grades I (0--29%), II (30--49%), III (50--59%), IV (60--69%), V (70--79%), VI (80--89%), VII (90--99%), and VIII (100%) ([@B4]).

Stenosis progression was defined as an increase in the degree of stenosis by at least one category. The progression of stenosis in either one or both ICAs was considered as progressive disease. Any change in ICA stenosis in either one or both ICA to a higher grade was considered stenosis progression ([@B13], [@B14]). The patient\'s stenosis grade was defined on the basis of the stenosis grade of the ICA side with the most severe stenosis.

Statistical methods
-------------------

This study involved 179 patients and 358 vessels. Univariate analysis was performed on the basis of λ^2^. An odds ratio was used to measure the association between the grade of stenosis and the risk of stenosis progression. Multivariable logistic regression analysis was used to analyze the risk factors of stenosis progression in the ICA. The results of the logistic regression models are presented as the odds ratio (OR) and the 95% CI. A two-sided *P* \< 0.05 was considered as statistically significant. Calculations were performed with SPSS for Windows (version 20.0, SPSS Inc).

Results {#s3}
=======

A total of 191 patients were admitted to our hospital for stroke and underwent carotid sonography during hospitalization and at 3 years after stroke onset. Among these 191 patients, eight patients were excluded because the severity of their ICA stenosis exceeded 70%, and two were excluded because the initial severity of their stenosis was less than 70% stenosis but the Follow up carotid sonography showed the patient had received stent implantation. Two patients were excluded because of tortuosity in the carotid artery. The analysis included 179 patients. Patient characteristics are presented in Table [1](#T1){ref-type="table"}. The majority 79.9% (143/179) of patients had a history of hypertension; 32.9% (59/179) had pure hypertriglyceridemia; 41.3% (74/179) had hypercholesterolemia; and 29.6% (53/179) had hyper-LDL-c. All of the 179 patients were followed up regularly in the outpatient department of the hospital and regularly took antiplatelet medication (aspirin 100 mg qd, or clopidogrel 75mg qd). Medication for hypertension, diabetes mellitus, and hyperlipidemia were given when the patient had those disease. The physician adjusted statin administration (atorvastatin, Fluvastatin, rosuvstatin, pitavastatin) as necessary with the aim of maintaining a serum cholesterol level lower than 160 mg/dl and an LDL cholesterol level lower than 100 mg/dl. This study included 358 carotid arteries. Among the included vessels, 281, 60, 10, and 7 vessels had stenosis grades of 0--29%, 30--49%, 50--59%, and 60--69%, respectively (Tables [2](#T2){ref-type="table"}, [3](#T3){ref-type="table"}). Two patients had stenosis with a severity of \>50% in both ICA. Univariate analysis revealed that male sex (38.9% vs. 22.5%, *p* = 0.03), smoking (41.9% vs. 25%, *p* \< 0.01), hyper-LDL-c (43.4% vs. 25.4%, *p* = 0.02), and stenosis \>50% (51.7% vs. 22.7%, *p* \< 0.01) increase the risk of stenosis progression. Age, diabetes mellitus, hypertension, hypercholesterolemia, statin use and body mass index (BMI) are not associated with the risk of stenosis progression.

###### 

Characteristics of the study population (*n* = 179).

  **Characteristics**        **Total (*n* = 179)**   **Progress (*n* = 55)**   **No progress (*n* = 124)**   ***p*-value[^\*^](#TN1){ref-type="table-fn"}**
  -------------------------- ----------------------- ------------------------- ----------------------------- ------------------------------------------------
  Age, mean (SD) years       67.95 ± 11.39           70.74 ± 9.53              66.60 ± 11.99                 0.02
  **AGE (YEARS)**                                                                                            
   ≥65                       62                      14 (22.6%)                48 (77.4%)                    0.06
   \>65                      117                     41 (35.1%)                76 (64.9%)                    
  **SEX**                                                                                                    
   Women                     71                      13 (18.3%)                58 (81.7%)                    0.03
   Men                       108                     42 (38.9%)                66 (61.1%)                    
  **DIABETES MELLITUS**                                                                                      
   Yes                       63                      24 (38.1%)                39 (61.9%)                    0.08
   No                        116                     31 (26.7%)                85 (73.3%)                    
  **HYPERTENSION**                                                                                           
   Yes                       143                     47 (32.9%)                96 (67.1%)                    0.15
   No                        36                      8 (22.2%)                 28 (77.8%)                    
  **HYPER-LDL-C**                                                                                            
   Yes                       53                      23 (43.4%)                30 (56.6%)                    
   No                        126                     32 (25.4%)                94 (74.6%)                    0.02
  **HYPERCHOLESTEROLEMIA**                                                                                   
   Yes                       74                      28 (37.8%)                46 (62.2%)                    0.06
   No                        105                     27 (25.7%)                78 (74.3%)                    
  **STATIN**                                                                                                 
   Yes                       100                     34 (34%)                  66 (66%)                      0.18
   No                        79                      21 (26.6%)                58 (73.4%)                    
  **SMOKING**                                                                                                
   Yes                       83                      34 (41%)                  49 (59%)                      \< 0.01
   No                        96                      21 (21.9%)                75 (78.1%)                    
  **STENOSIS**                                                                                               
   0--29%                    119                     25 (21%)                  94 (79%)                      \< 0.01
   30--49%                   44                      20 (45.5%)                24 (54.5%)                    
   50--59%                   9                       5 (55.6%)                 4 (44.4%)                     
   60--69%                   7                       5 (74.1%)                 2 (28.6%)                     
  **BMI**                                                                                                    
    \< 24                    78                      21 (26.9%)                57 (73.1%)                    0.52
   24--29.9                  83                      29 (34.9%)                54 (65.1%)                    
   ≥30                       18                      5 (27.8%)                 13 (72.2%)                    

*χ^2^ test; Progression: patient had ICA stenosis progression at least one grade; Non-progression: patient without ICA stenosis progression; Hyper-LDL-c: patient serum LDL cholesterol level \> 130 mg/dl*.

###### 

Rate of carotid artery stenosis and risk of stenosis progression.

  **Stenosis[^\*^](#TN2){ref-type="table-fn"}**   **Total**   **Progress**   **OR**   ***p*-value**   **95% CI**
  ----------------------------------------------- ----------- -------------- -------- --------------- -------------
  0--29%                                          119         25             1                        
  30--49%                                         44          20             3.1      \< 0.01         1.49--6.56
  50--59%                                         9           5              4.7      0.03            1.17--18.80
  60--69%                                         7           5              9.4      \< 0.01         1.72--51.35

*Stenosis rate of the side with intensive stenosis*.

###### 

Results of ultrasound examination of the patients\' carotid arteries.

  **Age (years)**   **Baseline stenosis (grade)**   **Follow up stenosis (grade)**                              
  ----------------- ------------------------------- -------------------------------- --- --- ---- ---- ---- --- ---
  18--44            5                               1                                0   0   6    0    0    0   0
  45--59            31                              6                                1   0   26   9    0    2   1
  60--79            66                              32                               8   6   55   41   8    5   3
  ≥80               17                              5                                0   1   12   8    2    0   1
  Total             119                             44                               9   7   99   58   10   7   5

*Grade: stenosis grade of the side with intensive stenosis*.

Carotid stenosis rate and stenosis progression
----------------------------------------------

Among the 358 ICAs from 179 patients, 281 had grade I stenosis, 60 had grade II stenosis, 10 had grade III stenosis, and 7 had grade IV stenosis (Table [4](#T4){ref-type="table"}). After 3 years of follow-up, among the 281 vessels with grade I stenosis, 45 had progressed to grade II and two had progressed to grade III. Among the 60 vessels with grade II stenosis, 8 had progressed to grade III, three had progressed to grade IV, one had progressed to grade V, and one had progressed to grade VIII. Among the vessels with grade III stenosis, one and two had progressed to grades IV and V, respectively. Among vessels with grade IV stenosis, one vessel had progressed to grade VI (Table [4](#T4){ref-type="table"}). Among the 358 vessels, after 3 years of follow up, 68 showed stenosis progression, among which 11 presented drastic stenosis progression (stenosis progression ≥2 grades).

###### 

Stenosis rate and progression (358 vessels).

  **Stenosis**   **Total**   **1 grade**   **2 grade**   **3 grade**   **Over 3 grade**
  -------------- ----------- ------------- ------------- ------------- ------------------
  0--29%         281         45            2             0             0
  30--49%        60          8             3             1             1
  50--59%        10          1             2             0             0
  60--69%        7           0             1             0             0

*Stenosis: stenosis rate of each vessel at baseline, 1 Grade: stenosis progressed to upper one grade, 2 Grade: stenosis progressed to upper second grade, 3 Grade stenosis progressed to upper third grade. Over 3 Grade: stenosis progressed over three grade*.

Patients with stenosis rates of above 50% are at a higher risk of stenosis progression than those with stenosis rates of \< 50% (Table [1](#T1){ref-type="table"}). Among the 179 included patients, the risk of stenosis progression increased with the severity of stenosis (Table [2](#T2){ref-type="table"}). Of the 64 vessels exhibiting stenosis progression, 7 showed stenosis progression on the side with intensive stenosis, 17 showed stenosis progression on the side opposite the side with intensive stenosis, and 22 showed stenosis progression their baseline stenosis rate was in the same grade on both sides of the ICA. Nine patients presented stenosis progression on both sides of the ICA. The mean progression rate was 16.2 ± 10.6% in the 64 vessels with stenosis progression. This result showed that the stenosis progression rate was not higher on the intensive stenosis side.

Effect of hypercholesterolemia and statin use on the progression of carotid artery stenosis
-------------------------------------------------------------------------------------------

Hyper-LDL-c increased the risk of ICA stenosis progression but hypercholesterolemia did not. The use of statins did not affect the progression of stenosis in patients with hypercholesterolemia or hyper-LDL-c or in the patients without hypercholesterolemia (Table [5](#T5){ref-type="table"}).

###### 

Relationship between statin and the progression of carotid artery.

  **Characteristics**           **Statin use**   **Progress**   **Non progress**   ***P*-value[^\*^](#TN4){ref-type="table-fn"}**   
  ----------------------------- ---------------- -------------- ------------------ ------------------------------------------------ ------
  Hyperlipidemia *N* = 74       Yes              62             21 (33.9%)         41 (66.1%)                                       0.19
                                No               12             7 (58.3%)          5 (41.7%)                                        
  No hyperlipidemia *N* = 105   Yes              38             13 (34.2%)         25 (65.8%)                                       0.10
                                No               67             14 (20.9%)         53 (79.1%)                                       
  Hyper-LDL-c *N* = 53          Yes              45             19 (42.2%)         26 (57.8%)                                       0.71
                                No               8              4 (50%)            4 (50%)                                          

*χ^2^ test, Hyper-LDL-c: patient serum LDL cholesterol level \>130 mg/dl*.

Adjustment for confounding factors revealed that hyper-LDL-c increased the risk of stenosis progression, which also increased as the stenosis grade increased. Relative to patients with ICA stenosis \< 30%, patients with ICA stenosis \>60% were at a higher risk of carotid artery stenosis progression (OR: 6.61, *p* = 0.03) (Table [6](#T6){ref-type="table"}).

###### 

Factors that affect the progression of carotid artery stenosis.

  **Characteristics**     **Total**   **Progress**   **Odds ratio**   **95% CI**    ***P*-value\***
  ----------------------- ----------- -------------- ---------------- ------------- -----------------
  **AGE**                                                                           
    ≤ 65                  62          14 (22.6%)     1                              
   \> 65                  117         41 (35.0%)     1.63             0.72--3.65    0.23
  **SEX**                                                                           
   Men                    108         42 (38.9%)     1                              
   Women                  71          13 (18.3%)     0.44             0.16--1.16    0.09
  **DIABETES MELLITUS**                                                             
   No                     117         31 (26.5%)     1                              
   Yes                    62          24 (38.7%)     1.38             0.65--2.94    0.39
  **HYPERTENSION**                                                                  
   No                     36          8 (22.2%)      1                              
   Yes                    143         47 (32.9%)     1.66             0.60--4.54    0.32
  **SMOKING**                                                                       
   No                     96          21 (21.9%)     1                              
   Yes                    83          34 (41%)       1.39             0.54--3.55    0.48
  **Hyper-LDL-C**                                                                   
   No                     126         32 (25.4%)     1                              
   Yes                    53          23 (43.4%)     2.22             1.05--4.71    0.03
  **STENOSIS RATE**                                                                 
   0--29%                 119         25 (21%)       1                              
   30--49%                44          20 (45.5%)     2.33             1.05--5.17    0.03
   50--59%                9           5 (55.5%)      3.50             0.81--15.04   0.09
   60--69%                7           5 (71.4%)      6.61             1.01--39.61   0.03

*Logistic regression, Hyper-LDL-c: patient serum LD*.

During the follow-up period, among the 124 patients who did not exhibit ICA stenosis progression, 22 experienced recurrent stroke. Among the 55 patients who exhibited ICA stenosis progression, 11 experienced recurrent stroke. The recurrent stroke rates in the progression and non-progression groups were not significantly different (*p* = 0.39). Of the 11 patients who had ICA stenosis progression and recurrent stroke, two had posterior circulation infarct, four had a stroke on the same side as ICA stenosis progression and five had recurrent stroke on the side opposite stenosis progression. Recurrent stroke appears unrelated to ICA stenosis progression.

Discussion {#s4}
==========

We found that stenosis progressed in 17.9% (64/358) of ICA in 30.7% (55/179) of patients. Among the vessels, 15.1% (54/358) progressed by one grade, and 2.8% (10/358) of vessels progressed by two or more grades. Our results for the ICA stenosis progression rate correspond with those reported by Liapis et al., who showed that over 44 months of follow up, 19% of patients exhibited ICA stenosis progression. The incidence of stenosis progression was 24% in the patients who had initial stenosis severity ≥50% and 16% in patients who had initial stenosis severity \< 50% ([@B4]). We found that the incidence of progression was 16.8% (64/341) in vessels with \< 50% stenosis and 23.5% (4/17) in vessels with ≥50% stenosis. Nine patients exhibited bilateral ICA stenosis progression and 46 patients exhibited unilateral ICA stenosis progression.

Fabris et al. reported that diabetes mellitus and total cholesterol are associated with the narrowing of the carotid artery ([@B15]). We found that male sex, smoking, and the severity of carotid artery stenosis are associated with the progression of carotid artery atherosclerosis. However, advanced age and hypercholesterolemia do not increase the risk of progression of carotid artery atherosclerosis. Moreover, multiple logistic regression analysis revealed that sex and smoking do not increase the risk of carotid artery stenosis progression; hyper-LDL-c and severity of stenosis associated with carotid artery stenosis progression. Drastically reducing cholesterol levels can reverse the progression of carotid artery atherosclerosis. Furberg et al. showed that lovastatin therapy can regress intima thickening ([@B16]). Zhang et al. found that decreasing lower low-density lipoprotein cholesterol levels to \< 70 mg/dl can decrease plaque progression ([@B17]). We found that hyper-LDL-c increased the risk of stenosis progression but hypercholesterolemia do not affect the progression of carotid artery stenosis, and that statin use does not affect the progression of carotid artery stenosis in patients with and without hypercholesterolemia. The difference in results may be attributed to the inability of our patients to lower their LDL levels to less than 70 mg/dl.

We found that stenosis progression is asymmetric and tends to occur on either side, irrespective of the severity of stenosis. This result corresponds with the lack of association between stenosis progression and hyperlipidemia or statin use because hyperlipidemia and statin use generally affect all vessels, not only one.

Lipais et al. showed that in a population with any degree of asymptomatic stenosis or symptomatic stenosis \< 50% ([@B4]), age, sex, diabetes mellitus, hypertension, hypercholesterolemia, and smoking habit do not affect stenosis progression and that the overall mean annual stenosis progression rate is 3%. Moreover, 15% of the population will exhibit disease progression. We found that after 3 years of follow-up, the ICA stenosis progression rate was 16.2 ± 10.6%, which is lower than the rate reported by Lipais et al. We also showed that the effects of sex, age, diabetes mellitus, hypertension, hypercholesterolemia, and smoking habit on the progression of stenosis are not statistically significant. The difference in stenosis progression rates between our study and that of Lipais et al. may be related to differences in the characteristics of plaque. Lipais et al. found that echolucent plaques are associated with the increased incidence and rate of progression of stenosis ([@B4]). Many complex factors may affect the progression of carotid artery stenosis. Batagini et al. showed that patients with carotid artery progression have higher serum urea and fibrinogen levels than those without carotid artery stenosis progression ([@B18]) and those patients with high BMIs have a low risk of stenosis progression. We did not confirm these results. Instead, we found that BMI does not affect the progression of carotid artery stenosis (Table [1](#T1){ref-type="table"}). Kamarck et al. reported that daily activity levels are associated with the enhanced progression of carotid artery atherosclerosis ([@B19]). Cardiovascular reactivity is a risk factor in atherosclerosis progression. Peter et al. showed that reactivity to psychogenic stress is a predictor of the progression of atherosclerosis ([@B20]). Inflammation is also a risk factor of atherosclerosis ([@B21]). Schillinger et al. reported that elevated serum high-sensitivity C-reactive protein and serum amyloid A levels are associated with progressive atherosclerosis. Previous studies on carotid artery stenosis have mainly focused on the symptoms of stroke ([@B22], [@B23]).

We found that during 3 years of follow up, 17.9% (64/358) of vessels exhibited ICA stenosis progression. Most of the vessels exhibited ICA progression by one grade, indicating that the severity of stenosis progressed by 10--20%. Moreover, 2.79% (10/358) of the vessels progressed by two or more grades. After 3 years of follow up, eight vessels with mild or moderate stenosis progressed to severe stenosis (≥70%) and were considered potential candidates for endarterectomy or stent ([@B22]). No patients with ICA stenosis rates of 0--29% progressed to severe stenosis. However, carotid artery atherosclerosis progression is not uncommon; it was found in 27.6% (45/163) of patients with carotid artery stenosis \< 50%. The aim of carotid ultrasound examination is to identify potential candidates for carotid artery stent implantation or endarterectomy ([@B22], [@B24]). We suggest that patients with ICA stenosis rates \< 30% be followed up for more than 3 years, whereas those with ICA stenosis rates of 30--49% should be followed up every 3 years through carotid ultrasonography. Patients with stenosis \>50% may require annual carotid artery ultrasonography especially in patients who have hyper-LDL-c.

Our study is limited by its retrospective nature. We only investigated patients who were regularly followed up through carotid ultrasonography. Moreover, we did not investigate the characteristics of plaque, which may affect the progression of carotid atherosclerosis.
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